Erythropoietin treatment and the risk of hip fractures in hemodialysis patients

医学 促红细胞生成素 贫血 血液透析 红细胞生成 危险系数 内科学 比例危险模型 髋部骨折 骨重建 肾脏疾病 骨病 骨髓 泌尿科 外科 骨质疏松症 置信区间
作者
Sukanya Suresh,Elizabeth C. Wright,Daniel G. Wright,Kevin C. Abbott,Constance Tom Noguchi
出处
期刊:Journal of Bone and Mineral Research [Oxford University Press]
卷期号:36 (7): 1211-1219 被引量:9
标识
DOI:10.1002/jbmr.4297
摘要

ABSTRACT Erythropoietin (EPO) is the primary regulator of bone marrow erythropoiesis. Mouse models have provided evidence that EPO also promotes bone remodeling and that EPO-stimulated erythropoiesis is accompanied by bone loss independent of increased red blood cell production. EPO has been used clinically for three decades to treat anemia in end-stage renal disease, and notably, although the incidence of hip fractures decreased in the United States generally after 1990, it rose among hemodialysis patients coincident with the introduction and subsequent dose escalation of EPO treatment. Given this clinical paradox and findings from studies in mice that elevated EPO affects bone health, we examined EPO treatment as a risk factor for fractures in hemodialysis patients. Relationships between EPO treatment and hip fractures were analyzed using United States Renal Data System (USRDS) datasets from 1997 to 2013 and Consolidated Renal Operations in a Web-enabled Network (CROWNWeb) datasets for 2013. Fracture risks for patients treated with <50 units of EPO/kg/week were compared to those receiving higher doses by multivariable Cox regression. Hip fracture rates for 747,832 patients in USRDS datasets (1997–2013) increased from 12.0 per 1000 patient years in 1997 to 18.9 in 2004, then decreased to 13.1 by 2013. Concomitantly, average EPO doses increased from 11,900 units/week in 1997 to 18,300 in 2004, then decreased to 8,800 by 2013. During this time, adjusted hazard ratios for hip fractures with EPO doses of 50–149, 150–299, and ≥ 300 units/kg/week compared to <50 units/kg/week were 1.08 (95% confidence interval [CI], 1.01–1.15), 1.22 (95% CI, 1.14–1.31), and 1.41 (95% CI, 1.31–1.52), respectively. Multivariable analyses of 128,941 patients in CROWNWeb datasets (2013) replicated these findings. This study implicates EPO treatment as an independent risk factor for hip fractures in hemodialysis patients and supports the conclusion that EPO treatment may have contributed to changing trends in fracture incidence for these patients during recent decades. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xymy发布了新的文献求助10
1秒前
小胡同学完成签到,获得积分10
1秒前
xiaofan发布了新的文献求助10
1秒前
含蓄的赛君完成签到,获得积分10
1秒前
论英雄发布了新的文献求助30
2秒前
2秒前
小二郎应助囚徒采纳,获得10
3秒前
3秒前
3秒前
巴卡发布了新的文献求助10
4秒前
CAOHOU应助含蓄的赛君采纳,获得10
5秒前
5秒前
5秒前
Singularity应助风中的一德采纳,获得10
6秒前
思源应助xymy采纳,获得10
7秒前
bkagyin应助灯灯采纳,获得10
7秒前
qiang完成签到,获得积分10
7秒前
在水一方应助包容的瑾瑜采纳,获得10
7秒前
8秒前
此晴可待完成签到,获得积分10
8秒前
8秒前
ajun发布了新的文献求助30
9秒前
juphen2发布了新的文献求助10
9秒前
CAOHOU应助清雨潇璇采纳,获得10
9秒前
9秒前
顾矜应助xiaofan采纳,获得10
10秒前
所所应助黎明采纳,获得10
10秒前
缓慢的香芦完成签到,获得积分10
11秒前
www完成签到 ,获得积分10
12秒前
boshi发布了新的文献求助10
12秒前
12秒前
ZYao65发布了新的文献求助10
12秒前
YHJX完成签到,获得积分10
13秒前
博修发布了新的文献求助10
13秒前
彪壮的火车完成签到,获得积分10
13秒前
坦率的匪应助七月流火采纳,获得10
14秒前
siqi发布了新的文献求助10
14秒前
14秒前
量子星尘发布了新的文献求助10
14秒前
14秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Handbook of Marine Craft Hydrodynamics and Motion Control, 2nd Edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3987223
求助须知:如何正确求助?哪些是违规求助? 3529513
关于积分的说明 11245651
捐赠科研通 3268108
什么是DOI,文献DOI怎么找? 1804027
邀请新用户注册赠送积分活动 881303
科研通“疑难数据库(出版商)”最低求助积分说明 808650